Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Agilent Technologies Inc (A) vs iShares iBoxx $ Inv Grade Corporate Bond ETF (LQD) Price & Performance

Agilent Technologies IncTrade
iShares iBoxx $ Inv Grade Corporate Bond ETFTrade

Price performance (Past 24H)

Key statistics

Agilent Technologies Inc vs iShares iBoxx $ Inv Grade Corporate Bond ETF — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while iShares iBoxx $ Inv Grade Corporate Bond ETF trades at $105.99. The key difference: Agilent Technologies Inc pays a 0.69% dividend while iShares iBoxx $ Inv Grade Corporate Bond ETF pays none, and Agilent Technologies Inc is trading nearer its 52-week high, iShares iBoxx $ Inv Grade Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.

ALQD
Market Cap
$42.00B
Sector
Health
52-Week High
$157.20$112.91
52-Week Low
$110.24$105.96
Enterprise Value
$43.55B
Dividend Yield
0.69%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Agilent Technologies Inc

Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.

The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.

iShares iBoxx $ Inv Grade Corporate Bond ETF

LQD trades at $106.55, showing modest daily gains of 0.18% amid a bearish technical outlook with moving averages signaling caution. The ETF maintains consistent dividend distributions, with recent payments ranging from $0.38 to $0.46 per share. Market sentiment reflects uncertainty around Federal Reserve policy and inflation trends, with bond yields fluctuating based on oil price movements and geopolitical tensions.

Investment opportunities include exposure to investment-grade corporate bonds with regular income distribution, while risks center on interest rate sensitivity and macroeconomic volatility. The fund's performance remains tied to credit market conditions and Federal Reserve policy decisions, with technical indicators suggesting near-term pressure despite neutral oscillator readings.

Returns comparison

Trailing returns across standard periods

About Agilent Technologies Inc

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.

Read more on A

About iShares iBoxx $ Inv Grade Corporate Bond ETF

The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in fixed income securities of the types included in the underlying index that the advisor believes will help the fund track the underlying index. The underlying index is designed to provide a broad representation of the US dollar-denominated liquid investment-grade corporate bond market.

Read more on LQD